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Amyloidogenic peptides are well known for their involvement in diseases
such as type 2 diabetes and Alzheimer’s disease. However, more recently,
amyloid fibrils have been shown to provide scaffolding and protection as
functional materials in a range of organisms from bacteria to humans.
These roles highlight the incredible tensile strength of the cross-b amyloid
architecture. Many amino acid sequences are able to self-assemble to form
amyloid with a cross-b core. Here we describe our recent advances in under-
standing how sequence contributes to amyloidogenicity and structure. For
example, we describe penta- and hexapeptides that assemble to form differ-
ent morphologies; a 12mer peptide that forms fibrous crystals; and an eight-
residue peptide originating from a-synuclein that has the ability to form
nanotubes. This work provides a wide range of peptides that may be
exploited as fibrous bionanomaterials. These fibrils provide a scaffold
upon which functional groups may be added, or templated assembly may
be performed.1. Introduction
Amyloid fibrils are formed by numerous proteins and peptides that have been
most commonly described in their pathogenic form. Over 30 proteins are
known to abnormally self-assemble to form amyloid fibrils, which are depos-
ited in tissues and are related to diseases such as Alzheimer’s disease, type 2
diabetes and familial amyloidotic polyneuropathy [1]. Each of the diseases is
characterized by a different protein that self-assembles and a broad range of pri-
mary sequences are able to form amyloid [2]. A number of algorithms have been
developed to explore how amyloidogenicity can be predicted from primary
sequence [2–4]. Collectively these in silico approaches reveal that the compo-
sition and position of side chains are important for amyloid formation [5].
Aromatic residues are essential and, in particular, phenylalanine and tyrosine
are found to drive assembly within numerous amyloidogenic sequences [6].
Amyloid fibrils are defined as sharing a well-defined three-dimensional,
repetitive fibrous structure. They are b-sheet rich and share a cross-b architec-
ture which can be detected using X-ray fibre diffraction [7]. The cross-b
structure was first defined for insect silk [8] and consists of b-strands that run
perpendicular to the fibre axis and elongate to form b-ribbons. Elongation of
the fibrils is predominantly mediated via hydrogen bonding between the
main chain, but the association of the b-sheet is stabilized by interactions
between the side chains [9,10]. The cross-b structure represents the core of
the protofilaments, and several protofilaments associate laterally to form the
mature fibril [11–13]. Importantly, small changes in the sequence of amyloido-
genic peptides can result in different morphologies arising from different
packing arrangements. Furthermore, substitutions can result in changes in the
propensity to self-assemble [14–17].
Relatively recently, amyloid fibrils have been discovered that play a
functional role in a range of organisms [18–20] including the formation of
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and PMEL17 in melanosomes [20]. This highlights the
potential for uses in applications that require highly stable,
self-assembling molecules.
Self-assembling molecules are increasingly used for the
production of polymeric materials, fibrous assemblies and
hydrogels with applications as diverse as photovoltaic cells
[22] to platforms for tissue engineering [23]. Amyloid fibrils
are extremely strong and stable structures [24,25], resistant
to degradation and can be strengthened even further with
intermolecular crosslinking [26,27]. They can be fragmented,
regenerated and can be used to make hydrogels and molecu-
lar scaffolds for further decoration [28]. Ultimately,
understanding the molecular basis of peptide self-assembly
could lead to the ability to harness amyloidogenesis for
the production of novel peptide-based materials, including
nanowires, nanotubes, laterally associated ribbons and
hydrogelating networks [28–30]. These structures have the
potential for use for a diverse range of applications such as
cell culture, cell adhesion, bio-sensing, cell differentiation,
long-acting drugs and cartilage regeneration [30–36]. For
example, the sequence of the C-terminus of the Alzheimer’s
related peptide, amyloid-b42 (Ab42), was varied and pro-
tected using 9-fluorenylmethoxycarbonyl to produce a
range of hydrogels that showed thixotropic properties
(shear thinning) and the ability to support cell growth [31].
The stiffness of the gels could be tuned using subtle changes
in peptide concentration and ionic strength with the possi-
bility that these gels could then be used to support
differentiation of stem cells. Interestingly, these gels sup-
ported viable cell growth in contrast with the expected
effects of the Ab42 peptide which is known to be cytotoxic
[37]. Peptides derived from the Parkinson’s disease (PD)
associated protein, a-synuclein, also form hydrogels that
could be further developed to support the growth of mesench-
ymal stem cells for substantia nigra graft implantation in a PD
mouse model [33]. For cellular growth, amyloidogenic pep-
tides can be further decorated with cell-adhesive sequences
such as RGD. These functional groups were found to alter
the topography of the surface of the fibrils and led to reduced
toxicity resulting in the ability to provide an attachment sur-
face for cell growth and spreading [32]. In another study,
two different peptides were developed that alone remained
soluble, but together formed a b-sheet rich hydrogel after
mixing. When an RGD sequence was also added to one of
the components, the ability to support 3T3 cell growth
was further improved and alteration of the ratios of the two
components allowed the gel stiffness to be tuned [30].2. The contribution of sequence to assembly
and structure
Many different sequences have the ability to self-assemble to
form amyloid fibrils. A series of short amyloidogenic pep-
tides have been crystallized to form microcrystals and their
assembled structures determined by X-ray crystallography
[10]. The first of these was GNNQQNY which is a sequence
derived from the yeast prion, Sup35 [38]. It was revealed
that this peptide is able to form at least two crystallographic
arrangements. The crystals have a hydrogen bonding direc-
tion, which is attributed to the fibre axis and the peptides
are arranged within the crystallographic structure to formsteric zippers in which the side chains associate and interdi-
gitate [10,38]. Further studies using solid-state NMR [39],
X-ray fibre diffraction [40] and small angle X-ray scattering
[41] revealed that the fibrillar structure differs from the
arrangement with the crystal packing. However, many
short peptide structures have been solved crystallographi-
cally [10,42–44], contributing valuable understanding of
how sequence contributes to stability within the amyloid
architecture. In order to better understand the role of
sequence in amyloidogenicity, a number of groups have
designed algorithms that explore the hydrophobicity,
b-sheet propensity and residue positional information
within the primary sequence [2–4,45,46]. Several of the algor-
ithms have been developed to further explore the structural
basis of amyloidogenicity by incorporating residue positional
and structural information [2,4]. One of these algorithms,
WALTZ, was developed using an experimentally validated
group of hexapeptides. In order to contribute further struc-
tural information to this algorithm, we explored three
peptides with the sequences HYFNIF, RVFNIM and VIYKI
[47]. All three of these peptides are strongly predicted to
form amyloid fibrils by WALTZ. Using a combined approach
of electron microscopy, X-ray fibre diffraction and linear
dichroism, we were able to generate model structures that
were consistent with the experimental data [47]. It is clear
from these three sequences that the aromatic residues (Y
and F) play an important role in the amyloidogenic propen-
sity as well as in the final structures. Interestingly, although
the sequences appear similar, the morphology of the fibrils
by electron microscopy differ significantly, whereby RVFNIM
forms twisted ropes and paired ribbons (figure 1a), VIYKI
forms fibrils that have a complex network of twisted protofila-
ments (figure 1b) and HYFNIF forms pairs of twisted
protofilaments (figure 1c). The diffraction patterns from each
of the fibrils formed by each of the peptides were analysed
and revealed the structures organize into different cross-b archi-
tectures (figure 1). A model of the structure for a HYFNIF
protofilament is shown in figure 1d. These structures highlight
the influence of primary sequence on the architecture of the
peptides within the protofilament and the packing of protofila-
ments which gives rise to the macromolecular morphology.
2.1. Aromatic and charged residues contribute to the
assembly, stability and structure of amyloid
The imperfect repeat peptide sequence KFFEAAAKKFFE
assembles to form fibrous nanocrystals. X-ray fibre diffraction
and electron microscopy were used to propose a model for
the structure of the fibrous architecture. In this arrangement,
the phenylalanine side chains play an important role in stabi-
lizing the three-dimensional structure, in both the fibrillar
and intersheet directions [9]. To explore the contribution of
sequence to the structure, a series of substituted peptides
were designed and the resulting fibrillar morphology and
molecular structure characterized. Importantly, substitution
of any phenylalanine for alanine resulted in assembly incom-
petent peptides, inferring that the p–p stacking of aromatic
residues is important for assembly and stability [9]. Others
have shown that phenylalanine can play an important role
in amyloidogenicity [6]. Indeed, di- and tri-phenylalanine
peptides have been shown to self-assemble to form fibrous,
amyloid-like structures [48,49]. To explore the role of charge
in the structure of KFFEAAAKKFFE, lysines were substituted
RVFNIM VIYKI HYFNIF HYFNIF
(a) (b) (c) (d)
Figure 1. Characterization of the structure of three amyloidogenic peptides identified by WALTZ [2]. Electron micrographs of fibrils formed by the sequences
(a) RVFNIM, (b) VIYKI and (c) HYFNIF, with the structures determined from X-ray fibre diffraction shown in the panels below. (d ) The structural model for a proto-
filament formed by HYFNIF, with the fibre shown above and the view down the fibre axis, highlighting the interdigitation of the side chains, shown below.
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to self-assemble, but those with lysine for alanine substi-
tutions formed narrow fibrils rather than the laterally
associated nanocrystals that are formed by wild-type, or argi-
nine variants. This result indicates that the lysine residues
play an essential role in the further lateral association that
takes place between protofilaments to form the crystalline
structures for KFFEAAAKKFFE [9,50] and suggests that sev-
eral of the lysines are exposed on the surface of the fibrils.
Many other studies have been conducted and show that the
position of particular amino acids in the sequence can influ-
ence the organization of the protofilaments [2,47,51–53].
Contribution of basic amino acids to assembly and lateral
association have been previously explored using a peptide
with sequence (VK)4-VPPT-(KV)4. The proline residues in
the centre of the precursor peptide prevented twisting and
allowed the formation of flat, laterally associated proto-
filaments [54]. Hydrophobicity of the sequence has been
shown to be essential for the amyloidogenicity [6,55].
MAX3 is a designed sequence containing two repeating VK
motifs separated by a threonine flanked D-proline-L-proline
region which produces a hairpin [55]. The peptide self-
assembles with increasing temperature as the hydrophobic
regions self-associate and assembly can be reversed by cool-
ing. The properties of the peptides can be tuned by altering
the hydrophobic content of the sequence [55]. The aromatic
content of amyloidogenic sequences has been highlighted
particularly in reference to the contribution of phenylalanine
[6] and tyrosine [16,47,56]. Structures of amyloidogenic pep-
tides have revealed that association of aromatic residues can
stabilize the structures [9,10,47,57,58]. Furthermore, theformation of dityrosine, whereby a covalent bond is formed
between two close tyrosine residues under oxidative con-
ditions, has been shown to increase the stability of amyloid
fibrils [26,59,60].2.2. Decorating the exterior of amyloid fibrils
The ability to decorate amyloid fibrils formed by self-assembled
b-sheet peptides is of considerable interest and has been
reported in a number of studies. For example, preformed fibrils
assembled from a (Ala)10-(His)6 amphiphilic peptide were
decorated with nanogold [61]. Pilkington et al. [62] showed
that fibrils could be decoratedwith an enzyme, glucose oxidase,
which remained folded and functional, retaining the ability to
inhibit the growth of Escherichia coli. Amyloid fibrils formed
by a yeast prion (N-terminal and middle (NM) region of
Sup35) in which surface exposed cysteine residues were
introduced, were covalently functionalized using gold and
silver deposition to produce conducting nanowires [29].
Alternatively, the amyloidogenic region can be conjugated
with the functional domain and then assembled. An excellent
example is a study using an SH3 domain peptide, which was
produced as a cytochrome b562 fusion protein and then
allowed to self-assemble to form amyloid fibrils under con-
trolled conditions. The fibrils formed were able to bind
metalloporphyrins in 50% of the constituent molecules [63].
Diatom cells are beautifully elaborate silica shells that
have nanoscale hooks, holes and gorges that are believed
to be formed by a fibrous protein core [64,65]. Indeed, it
has been previously shown that fibrous proteins can mediate
templating of tetraethyl orthosilicate to form silica [66–68]
KFFEAAAKKFFE
KFFEAAAKRFFE
0.2 mm 0.2 mm 50 nm
(a)
(c) (d )(b)
Figure 2. Exploiting fibrils formed by the sequence KFFEEAAAKKFFE [9,50]. (a) Structural models elucidated from X-ray fibre diffraction and electron diffraction data
[9]. (b) Electron microscopy shows that the variant peptide K9R forms amyloid-like fibrils, (c) which can be coated with silica to form silica nanowires. (d ) Silica
nanowires following embedding in resin and sectioning to highlight the exterior density from the silica and the electron lucent core [71].
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templating process [67–69]. In recent work, we used the
library of variants of the sequence ‘KFFEAAAKKFFE’ to
explore whether these fibrils can form silica wires and how
the sequence contributes to the morphology of the resulting
structures. Yuwono et al. compared the templating of tetra-
ethyl orthosilicate by a series of peptide amphiphiles and
revealed that His and Lys were important for calcination,
while glutamate was not sufficient to template silica [68].
Preformed fibrils composed of KFFEAAAKKFFE variants
were incubated with tetraethyl orthosilicate and then washed
with ethanol and water. The morphologies of resulting struc-
tures were investigated using electron microscopy, which
revealed that the alanine mutants were less able to template
silica and that lysine at position 1 was particularly important
to enable the fibrils to become coated. Arginine variants were
efficiently coatedwith silica and some formed very highlyorga-
nized silica nanowires with diameters of 70 nm [70] (figure 2).
Fourier transform infrared spectroscopy and X-ray fibre diffrac-
tion of the silica nanowires revealed that the cross-b core of the
nanowires remained after templating. Furthermore, after incu-
bation in a range of harsh conditions, such as low pH, organic
solvents and high temperatures, the silica nanowires retai-
ned their organized fibrous structure [71] indicating that they
could be useful for bionanotechnological processes as narrowwires. In summary, we demonstrated that amyloidogenic argi-
nine–lysine containing peptides represent a viable nucleus for
templating silica to produce very stable nanowires.2.3. Cross-b with an alternative morphology
Short amyloidogenic sequences have the possibility of form-
ing amyloid-like fibrils, and also more elaborate structures.
A short peptide derived from Ab16-22 (Ac-KLVFF-NH2)
was shown to form conventional amyloid fibrils at neutral
pH or to form distinctive, thin-walled nanotubes at low pH
[72]. A model of the peptides in the nanotube architecture
was built from X-ray and electron diffraction data with
b-strands tilted at 238 from the fibre axis [72]. An octapeptide
(VLYVGSKT) derived from a predicted b-strand within the
Parkinson’s related protein, a-synuclein [73], was found to
form cylindrical nanotubes following incubation at high
concentration in water [74]. These appear to be very lightly
stained tubes under the electron microscope, which resemble
thin-walled cylinders that occasionally unravelled from a tub-
ular structure to expose helical ribbons (figure 3a). We
conducted X-ray fibre diffraction analysis, which revealed a
cross-b pattern but with important differences arising from
the helical architecture and texture within the diffracting
samples [74]. Modelling revealed that the amphipathic
(a) (c)
V L Y V G S K T
hydrophobic region
hydrophilic region
(b)
closing
Figure 3. VLYVGSKT forms helical nanotubes and nanoribbons [74]. (a) Electron micrograph showing the thin-walled cylinders formed by the octapeptide. (b) The
structural model built following analysis of X-ray fibre diffraction data. (c) Helical nanotube and nanoribbon model proposed to incorporate the amphipathic peptide
into a bilayer which forms the walls of the cylinder.
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bilayer forming the walls of the cylinder (figure 3b). In the
model, the hydrophobic regions of the peptide are shielded
from solvent by the inner and outer walls of the cylinder
and also when the helical ribbon structure seals to form a
tube (figure 3c) [74]. These fibres are excellent candidates
for decoration to form fluorescent nanotubes. By conjugating
a fluorescein moiety to the N- or C-termini of the peptide, we
were able to explore the assembly process and to generate flu-
orescent tubes. In support of the model structure (figure 3b,c)
the addition of a fluorescein tag (X-Fluo) to the hydrophobic
N-terminus prevented the formation of the tubes, resulting
only in narrow amyloid-like fibrils (figure 4a). Addition of
the fluorescein tag (Lys(Fluo)) to the hydrophilic C-terminus
resulted in the formation of nanotubes (150 nm) similar to
those formed by the wild-type peptide (250 nm). Interest-
ingly, unravelling of the nanotubes into nanoribbons was
not observed, unlike those structures formed by the wild-
type octamer. The addition of the uncharged lysine (linked
to the fluorescein) may have influenced the formation of a
more stable helical nanotube (figure 4b). Capping the hydro-
phobic N-terminus of the C-terminal tagged peptide
prevented the formation of nanotubes and resulted in only
short nanofibrils (figure 4c). Confocal microscopy images
demonstrated the formation of a network of fluorescent
fibres from N-terminal tagged peptide and a cluster of
narrow fluorescent fibres by the C-terminal tagged peptide.
Acetylated C-terminal tagged peptide appeared as small
fluorescent particles by confocal microscopy. The results
highlight the importance of a free N-terminus to preserve
the discrete nanotubular architecture. A unique feature of
the wild-type design is its ability to incorporate the fluor-
escein moiety within the hydrophilic surface and retain its
nanotubular structure.3. Conclusion
Amyloid fibrils have inherent strength and stability due to
their extensive hydrogen bonding along the fibre axis and
the contribution of hydrophobic, aromatic and electrostatic
interactions between side chains. The diverse amino acid
sequences of peptides that form amyloid fibrils result in an
extensive range of different morphologies each with unique
surface properties which can be used for chemical decoration
and functionalization. Here we have discussed three
examples of our work to demonstrate the wide range of
different amyloid fibrous structure that can be formed and
further functionalized with the potential for use in
bionanotechnology.4. Experimental methods
All methodologies for Waltz peptides and KKFFEAAAKFFE
peptides are described in [9,47,50,70,71].
Structural study of fluorescent labelled peptides. Peptides
were synthesized as C-terminal amides by Fmoc/t-Bu-
based solid-phase synthesis, as previously described [75].
The wild-type and C- and N-terminus labelled peptides
were dissolved in Milli-Q water (15 mgml21) and allowed
to self-assemble at room temperature. After 7 days, peptides
were placed in a lyophiliser (458C, 90 000 r.p.m.) for 1 h.
Samples (100–120 mgml21) from each peptide were then col-
lected and examined using transmission electron microscopy
and confocal microscopy. A measure of 4 ml of the fibril
samples was incubated on 400 mesh carbon-formvar coated
copper grids (Agar Scientific Ltd) for 2 min, washed with
Milli-Q, 0.2 mm filtered water for another 2 min and stained
using filtered uranyl acetate 2% w/v for 2 min. Grids were
examined using a Hitachi 7100 electron microscope operated
(Fluo)-XVLYVGSKT-NH2 H-VLYVGSKT-Lys(Fluo)-NH2
CH3CO
50 nm
0.2 mm
5 mm 5 mm 5 mm
0.2 mm 0.2 mm 0.2 mm
Ac-VLYVGSKT-Lys(Fluo)-NH2
(a) (c)(b)
Figure 4. Fluorescein tagging of VLYVGSKT at the N- or C-termini (composition is depicted in top panel). Upper panels show transmission electron micrographs
showing the fibres formed. Confocal microscopy images showing the fluorescence of the assembled structures are shown in the panels below. (a) N-terminus tagged,
(b) C-terminus tagged, (c) N-terminus acetylated and C-terminus tagged. The X in the sequence of the N-terminal tagged peptide is a spacer (6-aminohexanoic acid)
to provide a distance between the tag and the peptide sequence.
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1000 CCD camera (Gatan, Abingdon, UK). For confocal ima-
ging, 5 ml of sample (50 mgml21) was dried onto a clean
slide, and a coverslip was placed on top and sealed with
nail polish. Images were taken using a Leica TCS SP8 confocal
microscope with a 63 1.2 NA water objective. Samples wereexcited with a 488 nm laser line and emission collected
between 500 and 550 nm.
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